Decibel Therapeutics

+$0.11 (+4.93%) Today
$0.00 (0.00%) As of 8:00 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell DBTX and other ETFs, options, and stocks.

About DBTX

Decibel Therapeutics, Inc. discovers and develops medicines to protect, repair, and restore hearing. The firm focuses on hearing disorders, including noise-induced hearing loss, residual hearing preservation or improved sound fidelity with cochlear implants, presbycusis or age-related hearing loss, tinnitus, a persistent ringing in the ears, and genetic hearing loss.

CEO
Laurence E. Reid
Employees
62
Headquarters
Boston, Massachusetts
Founded
2015

DBTX Key Statistics

Market cap
58.42M
Price-Earnings ratio
—
Dividend yield
—
Average volume
62.08K
High today
$2.32
Low today
$2.20
Open price
$2.25
Volume
16.37K
52 Week high
$9.75
52 Week low
$1.83

DBTX Earnings

-$1.09
-$0.73
-$0.36
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 10, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure